From: Free hemoglobin concentration in severe sepsis: methods of measurement and prediction of outcome
Postoperative patients | Survivors of severe sepsis | Non-survivors of severe sepsis | |
---|---|---|---|
Patient characteristics | |||
Patients, n | 136 | 111 | 50 |
Age, years | 60 (46, 69) | 60 (48, 72) | 56 (49, 66) |
Gender, male/female | 68/68 | 64/47 | 28/22 |
Disease severity | |||
SAPS II score | 21.5 (16.0, 27.3) | 44.0 (31.0, 57.0) | 54.0 (40.0, 60.5) |
SOFA score | 3.0 (1.8, 6.0) | 11.0 (8.0, 14.0) | 12.0 (10.0, 15.0) |
Procalcitonin, ng/ml | 1.5 (0.5, 3.7) | 3.2 (1.0, 16.0) | 3.8 (1.1, 16.7) |
Primary diagnosis ( n =) | |||
GI disease | 20 | 31 | 17 |
GI cancer | 40 | 16 | 10 |
Cancer other | 22 | 7 | 6 |
Urogenital disease | 6 | 3 | 2 |
Urogenital cancer | 18 | 3 | 2 |
Cardiovascular | 0 | 24 | 4 |
Lung disease | 0 | 19 | 5 |
Lung cancer | 0 | 1 | 2 |
Other diseases | 30 | 7 | 2 |
Infection type (in %) | |||
Gram positive | 0 | 42.9 | 34.7 |
Gram negative | 0 | 36.1 | 32.6 |
Fungal | 0 | 14.2 | 18.4 |
Cultures negative | 0 | 6.8 | 14.3 |
Kidney function | |||
Urea, mg/l | 140 (100, 203) | 410 (230, 540) | 490 (300, 745) |
Dialysis, % patients | 29.4 | 45.9 | 80.0 |